BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 34724763)

  • 1. A Profile of Glucose-6-Phosphate Dehydrogenase Variants and Deficiency of Multicultural Families in Korea.
    Bahk YY; Ahn SK; Lee J; Im JH; Yeom JS; Park S; Kwon J; Kan H; Kim M; Jang W; Kim TS
    Korean J Parasitol; 2021 Oct; 59(5):447-455. PubMed ID: 34724763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First evaluation of glucose-6-phosphate dehydrogenase (G6PD) deficiency in vivax malaria endemic regions in the Republic of Korea.
    Goo YK; Ji SY; Shin HI; Moon JH; Cho SH; Lee WJ; Kim JY
    PLoS One; 2014; 9(5):e97390. PubMed ID: 24853873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of glucose-6-phosphate dehydrogenase (G6PD) deficiency prevalence in a Plasmodium vivax-endemic area in the Republic of Korea (ROK).
    Lee W; Lee SE; Lee MJ; Noh KT
    Malar J; 2020 Sep; 19(1):317. PubMed ID: 32873296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. G6PD deficiency alleles in a malaria-endemic region in the Western Brazilian Amazon.
    Dombrowski JG; Souza RM; Curry J; Hinton L; Silva NRM; Grignard L; Gonçalves LA; Gomes AR; Epiphanio S; Drakeley C; Huggett J; Clark TG; Campino S; Marinho CRF
    Malar J; 2017 Jun; 16(1):253. PubMed ID: 28619120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of G6PD deficiency and submicroscopic malaria parasites carriage in malaria hotspot area in Northwest, Tanzania.
    Manjurano A; Lyimo E; Kishamawe C; Omolo J; Mosha J; Donald M; Kazyoba P; Kapiga S; Changalucha J
    Malar J; 2023 Dec; 22(1):372. PubMed ID: 38062464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of glucose-6-phosphate dehydrogenase (G6PD) deficiency in Gia Lai Province, Vietnam.
    Võ TC; Lê HG; Kang JM; Nguyễn ĐTD; Nguyễn TH; Yoo WG; Goo YK; Thi Minh Trinh N; Van Khanh C; Hong Quang H; Na BK
    Parasitol Int; 2024 Jun; 100():102868. PubMed ID: 38387679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of G6PD Viangchan variant in malaria endemic areas in Lao PDR: an implication for malaria elimination by 2030.
    Ong KIC; Iwagami M; Araki H; Khattignavong P; Soundala P; Keomalaphet S; Prasayasith P; Lorpachan L; Xangsayalath P; Pongvongsa T; Hongvanthong B; Brey PT; Kano S; Jimba M
    Malar J; 2019 Mar; 18(1):75. PubMed ID: 30866940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. G6PD deficiency at Sumba in Eastern Indonesia is prevalent, diverse and severe: implications for primaquine therapy against relapsing Vivax malaria.
    Satyagraha AW; Sadhewa A; Baramuli V; Elvira R; Ridenour C; Elyazar I; Noviyanti R; Coutrier FN; Harahap AR; Baird JK
    PLoS Negl Trop Dis; 2015 Mar; 9(3):e0003602. PubMed ID: 25746733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucose-6-phosphate dehydrogenase deficiency prevalence and genetic variants in malaria endemic areas of Colombia.
    Valencia SH; Ocampo ID; Arce-Plata MI; Recht J; Arévalo-Herrera M
    Malar J; 2016 May; 15(1):291. PubMed ID: 27225440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of glucose-6-phosphate dehydrogenase activity using CareStart G6PD rapid diagnostic test and associated genetic variants in Plasmodium vivax malaria endemic setting in Mauritania.
    Djigo OKM; Bollahi MA; Hasni Ebou M; Ould Ahmedou Salem MS; Tahar R; Bogreau H; Basco L; Ould Mohamed Salem Boukhary A
    PLoS One; 2019; 14(9):e0220977. PubMed ID: 31525211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An Evaluation of a New Quantitative Point-of Care Diagnostic to Measure Glucose-6-phosphate Dehydrogenase Activity.
    Bahk YY; Ahn SK; Jeon HJ; Na BK; Lee SK; Shin HJ
    Korean J Parasitol; 2022 Aug; 60(4):281-288. PubMed ID: 36041490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of Glucose 6-Phosphate Dehydrogenase Variants in Malaria-Endemic Areas of South Central Timor, Eastern Indonesia.
    Sulistyaningrum N; Arlinda D; Hutagalung J; Sunarno S; Oktoberia IS; Handayani S; Ekowatiningsih R; Yusnita EA; Prasetyorini B; Rizki A; Tjitra E; Na-Bangchang K; Chaijaroenkul W
    Am J Trop Med Hyg; 2020 Aug; 103(2):760-766. PubMed ID: 32602432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of hemolysis in Plasmodium vivax malaria patients receiving standard primaquine treatment in a population with high prevalence of G6PD deficiency.
    Liu H; Zeng W; Malla P; Wang C; Lakshmi S; Kim K; Menezes L; Yang Z; Cui L
    Infection; 2023 Feb; 51(1):213-222. PubMed ID: 35976559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetics of glucose-6-phosphate dehydrogenase (G6PD) activity during Plasmodium vivax infection: implications for early radical malaria treatment.
    Dahuron L; Goungounga J; Drame M; Douine M; Nacher M; Blaise T; Mosnier E; Musset L; Fouillet M; Djossou F; Epelboin L
    Malar J; 2024 May; 23(1):140. PubMed ID: 38725027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. G6PD deficiency: global distribution, genetic variants and primaquine therapy.
    Howes RE; Battle KE; Satyagraha AW; Baird JK; Hay SI
    Adv Parasitol; 2013; 81():133-201. PubMed ID: 23384623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and distribution of G6PD deficiency: implication for the use of primaquine in malaria treatment in Ethiopia.
    Lo E; Zhong D; Raya B; Pestana K; Koepfli C; Lee MC; Yewhalaw D; Yan G
    Malar J; 2019 Oct; 18(1):340. PubMed ID: 31590661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primaquine ineligibility in anti-relapse therapy of Plasmodium vivax malaria: the problem of G6PD deficiency and cytochrome P-450 2D6 polymorphisms.
    Baird JK; Battle KE; Howes RE
    Malar J; 2018 Jan; 17(1):42. PubMed ID: 29357870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-Nucleotide Polymorphisms in Glucose-6-Phosphate Dehydrogenase and their Relevance for the Deployment of Primaquine as a Radical Cure for Malaria.
    Nain M; Gill J; Mohan M; Sharma A
    Am J Trop Med Hyg; 2023 Mar; 108(3):470-476. PubMed ID: 36746659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of glucose-6-phosphate dehydrogenase (G6PD) deficiency among malaria patients in Upper Myanmar.
    Lee J; Kim TI; Kang JM; Jun H; Lê HG; Thái TL; Sohn WM; Myint MK; Lin K; Kim TS; Na BK
    BMC Infect Dis; 2018 Mar; 18(1):131. PubMed ID: 29548282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of primaquine in malaria infected patients with red cell glucose-6-phosphate dehydrogenase (G6PD) deficiency in Myanmar.
    Myat-Phone-Kyaw ; Myint-Oo ; Aung-Naing ; Aye-Lwin-Htwe
    Southeast Asian J Trop Med Public Health; 1994 Dec; 25(4):710-3. PubMed ID: 7667719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.